|
1
|
Chie WC, Blazeby JM, Hsiao CF, Chiu HC, Poon RT, Mikoshiba N, Al-Kadhim G, Heaton N, Calara J, Collins P, Caddick K, Costantini A, Vilgrain V. Differences in health-related quality of life between European and Asian patients with hepatocellular carcinoma. Asia Pac J Clin Oncol 2016; 13:e304-e311. [PMID: 27038366 DOI: 10.1111/ajco.12464] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2015] [Revised: 10/11/2015] [Accepted: 01/13/2016] [Indexed: 12/12/2022]
Abstract
AIM The aim of this study is to explore the possible effects of clinical and cultural characteristics of hepatocellular carcinoma on patients' health-related quality of life (HRQoL). METHODS Patients with hepatocellular carcinoma from Asian and European countries completed the EORTC QLQ-C30 and the EORTC QLQ-HCC18. Comparisons were made using Student's t-test and Wilcoxon rank-sum test with method of false discovery to correct multiple comparisons. Multiway analysis of variance and model selection were used to assess the effects of clinical characteristics and geographic areas. RESULTS Two hundred and twenty-seven patients with hepatocellular carcinoma completed questionnaires. After adjusting for demographic and clinical characteristics, Asian patients still had significantly better HRQoL scores in emotional functioning, insomnia, (QLQ-C30) and in sexual interest (QLQ-HCC18). We also found an interaction in physical functioning (QLQ-C30) and fatigue (QLQ-HCC18) between geographic region and marital status, married European had worse HRQoL scores than Asian singles. CONCLUSIONS Both clinical characteristics and geographic areas affected the HRQoL in with hepatocellular carcinoma. Cultural differences and clinical differences in the pattern of disease due to active surveillance of Asian countries may explain the results.
Collapse
Affiliation(s)
- Wei-Chu Chie
- Department of Public Health, Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taiwan
| | - Jane M Blazeby
- Centre for Surgical Research, School of Social & Community Medicine, University of Bristol, Bristol, UK.,Division of Surgery, Head & Neck, University Hospitals Bristol NHS Foundation Trust, Bristol, UK
| | - Chin-Fu Hsiao
- Division of Clinical Trial Statistics, Institute of Population Health Sciences, National Health Research Institutes, Taiwan
| | - Herng-Chia Chiu
- Department of Healthcare Administration and Medical Informatics, Kaoshiung Medical University, Taiwan
| | - Ronnie T Poon
- Department of Surgery, University of Hong Kong, Queen Mary Hospital, Hong Kong, Japan
| | - Naoko Mikoshiba
- Department of Adult Nursing/Palliative Care Nursing, Graduate School of Medicine, University of Tokyo, Japan
| | | | - Nigel Heaton
- Institute of Liver Studies, King's College Hospital, London, UK
| | - Jozer Calara
- Institute of Liver Studies, King's College Hospital, London, UK
| | - Peter Collins
- Department of Hepatology, University Hospitals Bristol NHS Foundation Trust, Bristol, UK
| | - Katharine Caddick
- Department of Hepatology, University Hospitals Bristol NHS Foundation Trust, Bristol, UK
| | - Anna Costantini
- Psychoncology Unit, Sant'Andrea Hospital - Faculty of Medicine and Psychology Sapienza, University of Rome, Italy
| | - Valerie Vilgrain
- Assistance-Publique Hôpitaux de Paris, APHP, Hôpital Beaujon, Department of Radiology, Clichy, France.,Université Paris Diderot, Sorbonne Paris Cité, INSERM Centre de recherche Biomédicale Bichat Beaujon, Paris, France
| | -
- Division of Clinical Trial Statistics, Institute of Population Health Sciences, National Health Research Institutes, Taiwan
| |
Collapse
|